The research in our group mainly focus on:

1, Nanochemistry. We actively explore new methodologies (reactions) for synthesizing nanomaterials, including dendrimers, supermolecular hydrogelators, and inorganic nanoparticles for bioengineering applications.

2, Molecular and Cellular Imaging. We develop novel molecular probes for imaging or manipulating targeted biomolecules in normal and diseased states, usually for cancer early detection.

3, Imaging modality. We combine different imaging modalities for disease dignosis, therapy evaluation, et al.

Our lab welcome students/scholars with diverse backgrounds and expertise including synthetic and analytical chemistry, protein and nanoparticle engineering, molecular and cellular biology, medical imaging, and many more. Each individual plays crucial roles in multiple research projects and learn knowledge from each other in the interdisciplinary projects as well. We provide an excellent research and training environment for Ph.D. scientists and graduate students, medical students and residents.

*June 9, Congratulations! Ge Gao's paper titled "A Trident Molecule with Nanobrush-Nanoparticle-Nanofiber Transition Property Spatially Suppresses Tumor Metastasis." was accepted by J. Am. Chem. Soc.* 2022, Congratulations to Ge!
*May 26, Congratulations! Yue Hua's paper titled "Salt-inducible Kinase 2-Triggered Release of Its Inhibitor from Hydrogel to Suppress Ovarian Cancer Metastasis." was accepted by Adv. Sci.* 2022, 2202260 (DOI: 10.1002/advs.202202260). Congratulations to Yue!
*May 6, Congratulations! Lingling Xu's paper titled "ROS Turn Nanoparticle Fluorescence on for Imaging Staphylococcus aureus Infection in Vivo." was accepted by Adv. Healthcare Mater.* 2022, 208, 2200453 (DOI: 10.1002/adhm.202200453). Congratulations to Lingling!
*April 13, Congratulations! Xiang Shi's paper titled "An aminopeptidase N-activatable chemiluminescence probe for image-guided surgery and metastasis tracking of tumor." was accepted by Biosens. Bioelectron.* 2022, 208, 114212 (DOI: 10.1016/j.bios.2022.114212).Congratulations to Xiang!